BR112012021995A8 - Composição,célula hospedeira bacteriana não patogênica, método para a produção de um sulfato de condroitina,condroitina, composição e anticorpo ou fragmento de anticorpo - Google Patents
Composição,célula hospedeira bacteriana não patogênica, método para a produção de um sulfato de condroitina,condroitina, composição e anticorpo ou fragmento de anticorpoInfo
- Publication number
- BR112012021995A8 BR112012021995A8 BR112012021995A BR112012021995A BR112012021995A8 BR 112012021995 A8 BR112012021995 A8 BR 112012021995A8 BR 112012021995 A BR112012021995 A BR 112012021995A BR 112012021995 A BR112012021995 A BR 112012021995A BR 112012021995 A8 BR112012021995 A8 BR 112012021995A8
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- chondroitin
- antibody
- production
- host cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Materials Engineering (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
Abstract
CONSTRUÇÃO, CÉLULA HOSPEDEIRA BACTERIANA NÃO PATOGÊNICA, MÉTODO PARA A PRODUÇÃO DE UM SULFATO DE CONDROITINA, COMPOSIÇÃO E ANTICORPO OU FRAGMENTO DE ANTICORPO. A invenção está relacionada ao campo da tecnologia de DNA recombinante para a produção de condroitina, incluindo a produção de sulfato de condroitina por meio de uma combinação de fermentação bacteriana recombinante e sulfatação pós-fermentação.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30940710P | 2010-03-01 | 2010-03-01 | |
PCT/US2011/026748 WO2011109438A1 (en) | 2010-03-01 | 2011-03-01 | Compositions and methods for bacterial production of chondroitin |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112012021995A2 BR112012021995A2 (pt) | 2015-10-06 |
BR112012021995A8 true BR112012021995A8 (pt) | 2018-01-02 |
Family
ID=44542545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012021995A BR112012021995A8 (pt) | 2010-03-01 | 2011-03-01 | Composição,célula hospedeira bacteriana não patogênica, método para a produção de um sulfato de condroitina,condroitina, composição e anticorpo ou fragmento de anticorpo |
Country Status (8)
Country | Link |
---|---|
US (2) | US8697398B2 (pt) |
EP (1) | EP2542686B1 (pt) |
JP (1) | JP5875531B2 (pt) |
KR (1) | KR101848102B1 (pt) |
CN (1) | CN102869782B (pt) |
BR (1) | BR112012021995A8 (pt) |
ES (1) | ES2661593T3 (pt) |
WO (1) | WO2011109438A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5875531B2 (ja) | 2010-03-01 | 2016-03-02 | 生化学工業株式会社 | コンドロイチンの細菌生産のための組成物および方法 |
SI2591127T1 (sl) | 2010-07-09 | 2017-12-29 | Gnosis S.P.A. | Biotehnološka proizvodnja hondroitina |
WO2013172154A1 (ja) * | 2012-05-17 | 2013-11-21 | 東洋紡株式会社 | 担子菌酵母変異体 |
ITMI20120896A1 (it) | 2012-05-23 | 2013-11-24 | Bongulielmi Reto | Condroitina per uso in medicina |
ITMI20121316A1 (it) * | 2012-07-27 | 2014-01-28 | Altergon Sa | Complessi di condroitina ad assorbimento transcutaneo |
US9902756B2 (en) | 2012-11-16 | 2018-02-27 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Gonorrheal MtrE peptides and vaccines |
US20150247174A1 (en) * | 2012-12-28 | 2015-09-03 | Anhui Huaheng Bioengineering Co., Ltd, | Engineering bacteria for producing dl-alanine and method for producing dl-alanine by using engineering bacteria |
EP3053599A4 (en) * | 2013-09-30 | 2017-06-14 | Seikagaku Corporation | Method for improving blood persistence of protein |
FR3016637B1 (fr) * | 2014-01-23 | 2020-11-27 | Centre Nat Rech Scient | Procede de production in vivo de glycosaminoglycane |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
EP3050973A1 (en) * | 2015-01-30 | 2016-08-03 | Jennewein Biotechnologie GmbH | Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars |
US10259889B2 (en) | 2015-03-31 | 2019-04-16 | Seikagaku Corporation | Method for sulfating glycosaminoglycan |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
IT202000013633A1 (it) * | 2020-06-08 | 2021-12-08 | Vivatis Pharma Gmbh | Processo di estrazione di una condroitina solfato da un fungo, una condroitina solfato di origine vegetale e suo uso |
EP4067487A1 (en) | 2021-04-01 | 2022-10-05 | Givaudan SA | Chondroitin-producing recombinant cell |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030104601A1 (en) | 1999-04-01 | 2003-06-05 | Deangelis Paul L. | Chondroitin synthase gene and methods of making and using same |
WO2000027437A2 (en) | 1998-11-11 | 2000-05-18 | The Board Of Regents Of The University Of Oklahoma | Polymer grafting by polysaccharide synthases |
US20060105431A1 (en) | 1998-11-11 | 2006-05-18 | Deangelis Paul L | Polymer grafting by polysaccharide synthases using artificial sugar acceptors |
US6235510B1 (en) | 1999-08-18 | 2001-05-22 | Smithkline Beecham Corporation | ppGaNTase-T6 |
EP1233072B1 (en) | 1999-11-25 | 2006-08-02 | Yamasa Corporation | Novel use of uridine diphosphate glucose 4-epimerase |
DE10019881A1 (de) * | 2000-04-20 | 2001-11-15 | Gerhard Miksch | Verfahren zur Überexpression und extrazellulären Produktion bakterieller Phytasen in Escherichia coli |
EP1470235A4 (en) | 2001-07-13 | 2008-05-21 | Univ Oklahoma | GLYCOSAMINOGLYCAN POLYMERS AND METHODS OF PREPARING AND USING THE SAME |
JP4702819B2 (ja) | 2001-08-01 | 2011-06-15 | 生化学工業株式会社 | コンドロイチン合成酵素 |
JP4101548B2 (ja) | 2001-08-10 | 2008-06-18 | 生化学工業株式会社 | コンドロイチン合成酵素及びそれをコードするdna |
JP4338038B2 (ja) | 2002-05-31 | 2009-09-30 | 生化学工業株式会社 | コンドロイチン合成酵素および該酵素をコードする核酸 |
JP4333880B2 (ja) | 2002-05-31 | 2009-09-16 | 生化学工業株式会社 | コンドロイチン合成酵素および該酵素をコードするdna |
AU2005287397A1 (en) | 2004-06-30 | 2006-03-30 | Paul L. Deangelis | Methods of selectively treating diseases with specific glycosaminoglycan polymers |
ES2299284B1 (es) * | 2004-11-04 | 2009-04-16 | Universidad Pablo De Olavide | Control de la expresion genica mediante el uso de un atenuador de la transcripcion. |
US20080219960A1 (en) * | 2004-12-16 | 2008-09-11 | Masja Nathalie Nierop Groot | Novel Efficient Production Process for Capsular Polysaccharides of Pathogenic Grampositive Bacteria by Heterologous Expression and Secretion of Complex Polysaccharides in Non-Pathogenic, Non-Invasive Gram-Positive Bacteria |
JP5176114B2 (ja) * | 2005-06-06 | 2013-04-03 | フェネックス インコーポレイテッド | 細菌宿主細胞におけるマンニトール誘導のプロモーター系 |
EP1964924B1 (en) | 2005-12-15 | 2015-09-30 | Seikagaku Corporation | Long-chain chondroitin sugar chain and method for producing the same and method for promoting synthesis of chondroitin |
EP2690178B1 (en) | 2006-10-03 | 2021-12-22 | The Board Of Regents Of The University Of Oklahoma | Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same |
WO2008133350A1 (en) * | 2007-04-24 | 2008-11-06 | Seikagaku Corporation | Chondroitin-producing bacterium and method of producing chondroitin |
JP5875531B2 (ja) | 2010-03-01 | 2016-03-02 | 生化学工業株式会社 | コンドロイチンの細菌生産のための組成物および方法 |
SI2591127T1 (sl) | 2010-07-09 | 2017-12-29 | Gnosis S.P.A. | Biotehnološka proizvodnja hondroitina |
-
2011
- 2011-03-01 JP JP2012556184A patent/JP5875531B2/ja active Active
- 2011-03-01 US US13/038,326 patent/US8697398B2/en active Active
- 2011-03-01 ES ES11751231.9T patent/ES2661593T3/es active Active
- 2011-03-01 CN CN201180022154.5A patent/CN102869782B/zh active Active
- 2011-03-01 EP EP11751231.9A patent/EP2542686B1/en active Active
- 2011-03-01 WO PCT/US2011/026748 patent/WO2011109438A1/en active Application Filing
- 2011-03-01 BR BR112012021995A patent/BR112012021995A8/pt not_active Application Discontinuation
- 2011-03-01 KR KR1020127025916A patent/KR101848102B1/ko active IP Right Grant
-
2014
- 2014-02-20 US US14/185,639 patent/US9175293B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN102869782A (zh) | 2013-01-09 |
KR101848102B1 (ko) | 2018-04-11 |
JP2013520995A (ja) | 2013-06-10 |
EP2542686B1 (en) | 2018-01-03 |
CN102869782B (zh) | 2015-11-25 |
EP2542686A4 (en) | 2014-03-26 |
BR112012021995A2 (pt) | 2015-10-06 |
WO2011109438A1 (en) | 2011-09-09 |
US20110244520A1 (en) | 2011-10-06 |
ES2661593T3 (es) | 2018-04-02 |
US9175293B2 (en) | 2015-11-03 |
US8697398B2 (en) | 2014-04-15 |
JP5875531B2 (ja) | 2016-03-02 |
EP2542686A1 (en) | 2013-01-09 |
KR20130055571A (ko) | 2013-05-28 |
US20140296505A1 (en) | 2014-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012021995A8 (pt) | Composição,célula hospedeira bacteriana não patogênica, método para a produção de um sulfato de condroitina,condroitina, composição e anticorpo ou fragmento de anticorpo | |
BR112016023304A2 (pt) | célula hospedeira recombinante engendrada para superexpressar proteínas auxiliares | |
EP4036240A3 (en) | Transduction buffer | |
BR112013018307A2 (pt) | polipeptídeo isolado, composição, polinucleotídeo isolado, construto de ácido nucleico ou vetor de expressão, célula hospedeira recombinante, métodos para produzir um polipeptídeo e uma proteína, e, processos para degradar um material celulósico, para sintetizar um produto de fermentação, e para fermentar um material celulósico. | |
BR112012000260A2 (pt) | polipeptídeo isolado, composição, polinucleotídeo isolado, célula hospedeira, métodos para produzir um polipeptídeo, uma proteína e um produto de fermentação, para inibir a expressão de um polopeptídeo, para degradar ou converter um material celulósico, e para fermentar um material celulósico, planta, parte de planta ou célula de planta, e, molécula de rna inibidora de filamento duplo. | |
CL2011002611A1 (es) | Anticuerpo aislado anti-cadherina-17; molecula de acido nucleico que lo codifica; vector; celula huesped; metodo de produccion; inmunoconjugado que lo comprende; composicion que lo comprende; y su uso para tratar o prevenir una enfermedad asociada con celulas objetivo que expresan cadherina-17. | |
GB201020995D0 (en) | Biological materials and uses thereof | |
BR112012002137A2 (pt) | método para um polipeptídeo e/ou vírus de interesse em uma cultura de célula contínua,e, composição | |
CL2013001403A1 (es) | Anticuerpo monoclonal anti-ccl20 o un fragmento de unión del mismo; molecula de acido nucleico que lo codifica; vector; celula huesped; metodo de produccion; composicion que lo comprende; y su uso. | |
BR112013019038A2 (pt) | polipeptídeo isolado, polinucleotídeo isolado, célula hospedeira recombinante, métodos de produzir o polipeptídeo, de produzir um mutante de uma célula parental, de inibir a expressão de um polipeptídeo, de produzir uma proteína, para degradar ou converter um material celulósico, de produzir um produto de fermentação, de fermentar um material celulósico, planta transgênica, parte da planta ou célula de planta transformada com um polinucleotídeo, molécula de rna inibitório dupla fita (rnads), e, formulação completa de caldo ou composição de cultura de células. | |
BR112013016830A2 (pt) | polipeptídeo isolado, polinucleotídeo isolado, método de produzir o polipeptídeo, de produzir um mutante de uma célula parental, de inibir a expressão de um polipeptídeo, de produzir uma proteína, de degradar ou converter um material celulósico, de produzir um produto de fermentação e de fermentar um material celulósico, planta transgênica, parte da planta ou célula de planta transformada com um polinucleotídeo, molécula de rna de fita dupla, composição, e, formulação de caldo completo ou composição de cultura de células | |
BR112012027994A2 (pt) | anticorpo isolado, composição farmacêutica, ácido nucleico isolado, composições, célula hospedeira, métodos de tratar esclerose múltipla, artrite reumatoide, perda óssea osteolítica e câncer | |
WO2012045082A3 (en) | Engineered nucleic acids and methods of use thereof | |
CL2008002444A1 (es) | Anticuerpo o fragmento del mismo que se une a la proteina c-fms humana; molecula de acido nucleico que la codifica; vector y celula huesped; metodo de elaboracion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir una condicion asociada con c-fms en un paciente. | |
BR112012024287A2 (pt) | anticorpo, composição farmacêutica, método, ácido nucleico, vetor de expressão e célula hospedeira | |
BR112012031847A2 (pt) | cultura de produção para a produção fermentativa de butanol, método de produção de butanol, método para a produção de butanol, método para aumentar a tolerância de uma cultura de produção para a produção fermentativa de butanol e cultura de produção para produção fermentativa de butanol | |
MX354049B (es) | Método rápido para la clonación y expresión de segmentos génicos de regiones variables de anticuerpos cognados. | |
BR112012015255A2 (pt) | "anticorpo, composição farmaceutica, uso de um anticorpo,método de tramento ,ácido nucleico, vetor de espressão, célula hospedeira e método de produção de um anticorpo recobinante" | |
BRPI0819526B8 (pt) | Sequência de ácido nucleico de precursor de mirna artificial, construção recombinante e método para reduzir a expressão de uma sequência alvo | |
WO2011100749A3 (en) | Methods and materials for detecting viral or microbial infections | |
CL2011002360A1 (es) | Anticuerpo anti-alfa5beta1; molecula de acido nucleico que codifica el anticuerpo;celula huesped; metodo para produccionde anticuerpos anti-alfa5beta1; inmunoconjugado que comprende el anticuerpo; composicion farmaceutica. | |
EP4282881A3 (en) | Antibodies against csf-1r | |
MX2015011781A (es) | Medio de cultivo celular y metodos de produccion de anticuerpos. | |
BR112014004193A2 (pt) | célula hospedeira recombinante de trichoderma, métodos para produzir uma composição enzimática, composição enzimática, processos para degradar um material celulósico, para sintetizar um produto de fermentação e para fermentar um material celulósico | |
WO2012003402A3 (en) | Compositions and methods for culturing microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: SEIKAGAKU CORPORATION (JP) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |